Healthcare Payer Business Intelligence Solution Evolution, 2008-2010
| Publication Date | February 2008 |
|---|---|
| Publisher | IDC |
| Product Type | Report |
| Pages | 9 |
| ISBN Number | not applicable |
| Product Code | IDC04036 |
Summary
This Health Industry Insights report reviews major trends in business intelligence solutions from 2005 to 2007 and their effects on healthcare payer strategies and deployment through 2010.
Health Industry Insights surveys indicate that at least two-thirds of healthcare payer organizations plan to reassess business intelligence strategies through 2010 and to make business intelligence investments. Successful restructuring of the business intelligence and information management strategy depends on availability of strong proven solutions. However, the healthcare payer business intelligence market"perfect storm"of drivers is paralleled by a corresponding vendor solution market perfect storm of rapid market change and evolution.
"The U.S. healthcare payer business intelligence spending CAGR projection through 2011 is 12.4%, exceeding the average industry IT spending CAGR of 7%. High market demand, high spending projections, and a volatile market in transition all require new solution assessment criteria and management oversight,"says Janice Young, program director for Healthcare Payer IT Strategies.
Content
- Health Industry Insights Opinion
- In This Report
- Brief Description of the Solution
- Situation Overview
- A Brief History
- Consolidation/Enterprise Trends
- Expansion/Dynamic Tools Within Niche Healthcare Applications
- Merger and Acquisition Activity and Product Expansion Among Niche Healthcare Solutions Vendors
- Management Challenges
- Emerging Market Solution Dynamics
- Internal (Performance) Versus External (Transparency) Investment Management
- Underlying Business Intelligence Technology Partners
- External/Benchmark Support
- Emerging Technology
- A Brief History
- Future Outlook
- Future Adoption Patterns
- Market Trends
- Essential Guidance
- Actions to Consider
- Payers
- Vendors
- Actions to Consider
- Learn More
- Related Research
- Synopsis
About this Product
Delivery Details
PDF:Immediate delivery
Related Products
Recently Viewed Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















